TBP Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
$7.68M Sell
78,252
-370
-0.5% -$37.6K 4.76% 3
2014
Q4
$7.41M Sell
78,622
-7,310
-9% -$756K 4.84% 4
2014
Q3
$9.15M Sell
85,932
-500
-0.6% -$49K 5.34% 2
2014
Q2
$7.17M Sell
86,432
-680
-0.8% -$52.9K 4.2% 6
2014
Q1
$6.17M Buy
87,112
+590
+0.7% +$46.3K 3.84% 9
2013
Q4
$6.5M Sell
86,522
-765
-0.9% -$53.3K 4.17% 7
2013
Q3
$5.49M Sell
87,287
-8,285
-9% -$495K 3.8% 9
2013
Q2
$4.9M Buy
+95,572
New +$4.98M 3.32% 14

Other funds holding GILD

TBP Advisors's GILD Position: Q1 2015 in Review

TBP Advisors reduced its Gilead Sciences (GILD) stake by 0.47% in Q1 2015, selling an estimated $37.6K and leaving 78,252 shares worth $7.68M. The position accounts for 4.76% of the portfolio, ranked #3.

TBP Advisors first reported a position in GILD in Q2 2013 and has held it in 8 quarters since. The position peaked at $9.15M in Q3 2014. 1,492 funds tracked by Wall St. Rank hold GILD as of Q1 2015.

  • TBP Advisors held 78,252 shares of Gilead Sciences worth $7.68M as of Q1 2015.
  • TBP Advisors sold 370 Gilead Sciences shares in Q1 2015, an estimated $37.6K.
  • Gilead Sciences made up 4.76% of TBP Advisors's portfolio in Q1 2015, its #3 holding.
  • TBP Advisors first reported a position in Gilead Sciences in Q2 2013 and has held it in 8 quarters since.
  • TBP Advisors's Gilead Sciences position peaked at $9.15M in Q3 2014.
  • 1,492 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2015.

Based on TBP Advisors's 13F filing for Q1 2015, filed 17 Apr 2015.